Surya A. Reis

2.7k total citations · 1 hit paper
23 papers, 1.7k citations indexed

About

Surya A. Reis is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Surya A. Reis has authored 23 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Genetics and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Surya A. Reis's work include Genetics and Neurodevelopmental Disorders (9 papers), Histone Deacetylase Inhibitors Research (9 papers) and Protein Degradation and Inhibitors (6 papers). Surya A. Reis is often cited by papers focused on Genetics and Neurodevelopmental Disorders (9 papers), Histone Deacetylase Inhibitors Research (9 papers) and Protein Degradation and Inhibitors (6 papers). Surya A. Reis collaborates with scholars based in United States, Netherlands and Germany. Surya A. Reis's co-authors include Stephen J. Haggarty, Ben A. Oostra, Francesca Zalfa, Claudia Bagni, Alessandra di Penta, Steven D. Sheridan, Ralph Mazitschek, Jeanne F. Loring, Fen Zhou and Laurence Dahéron and has published in prestigious journals such as Cell, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Surya A. Reis

22 papers receiving 1.7k citations

Hit Papers

The Fragile X Syndrome Protein FMRP Associates with BC1 R... 2003 2026 2010 2018 2003 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Surya A. Reis United States 17 1.2k 588 254 251 145 23 1.7k
Pamela R. Westmark United States 18 476 0.4× 257 0.4× 168 0.7× 195 0.8× 92 0.6× 36 1.1k
Yusuke Hirabayashi Japan 22 2.3k 1.9× 498 0.8× 108 0.4× 677 2.7× 258 1.8× 40 3.3k
Christine Gentry United States 14 1.1k 0.9× 185 0.3× 128 0.5× 428 1.7× 75 0.5× 19 1.9k
Valle Palomo Spain 25 1.0k 0.9× 162 0.3× 64 0.3× 287 1.1× 249 1.7× 53 1.7k
Christine I. Nam United States 8 735 0.6× 122 0.2× 126 0.5× 524 2.1× 138 1.0× 8 1.4k
Alaa El‐Husseini Canada 20 1.7k 1.4× 351 0.6× 265 1.0× 1.5k 6.1× 67 0.5× 25 2.8k
Takeshi Uemura Japan 29 1.1k 0.9× 199 0.3× 175 0.7× 863 3.4× 82 0.6× 86 2.5k
Zhenyu Wu China 13 417 0.3× 445 0.8× 302 1.2× 154 0.6× 325 2.2× 37 1.3k
Ewa K. Stachowiak United States 32 2.1k 1.7× 307 0.5× 70 0.3× 625 2.5× 202 1.4× 63 3.1k
Krys S. Bankiewicz United States 28 1.8k 1.5× 520 0.9× 234 0.9× 1.9k 7.5× 64 0.4× 45 4.0k

Countries citing papers authored by Surya A. Reis

Since Specialization
Citations

This map shows the geographic impact of Surya A. Reis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Surya A. Reis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Surya A. Reis more than expected).

Fields of papers citing papers by Surya A. Reis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Surya A. Reis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Surya A. Reis. The network helps show where Surya A. Reis may publish in the future.

Co-authorship network of co-authors of Surya A. Reis

This figure shows the co-authorship network connecting the top 25 collaborators of Surya A. Reis. A scholar is included among the top collaborators of Surya A. Reis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Surya A. Reis. Surya A. Reis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Padget, Michael, Pernilla Sörme, Susan Slaugenhaupt, et al.. (2024). Environmental impact, cost, and acceptability of a laboratory sustainability certification program for biomedical research in an academic medical center. SHILAP Revista de lepidopterología. 23. 100401–100401.
2.
Fass, Daniel M., N. Connor Payne, Debasis Patnaik, et al.. (2024). Epigenetic modulation through BET bromodomain inhibitors as a novel therapeutic strategy for progranulin-deficient frontotemporal dementia. Scientific Reports. 14(1). 9064–9064. 6 indexed citations
3.
Wagh, Vilas, Surya A. Reis, Serkan Erdin, et al.. (2020). TSC patient-derived isogenic neural progenitor cells reveal altered early neurodevelopmental phenotypes and rapamycin-induced MNK-eIF4E signaling. Molecular Autism. 11(1). 2–2. 30 indexed citations
4.
Garza, Jacob C., Xiaoli Qi, Melanie P. Leussis, et al.. (2018). Disruption of the psychiatric risk gene Ankyrin 3 enhances microtubule dynamics through GSK3/CRMP2 signaling. Translational Psychiatry. 8(1). 135–135. 26 indexed citations
5.
Kurtser, Iren, Surya A. Reis, Krista M. Hennig, et al.. (2017). Selectivity and Kinetic Requirements of HDAC Inhibitors as Progranulin Enhancers for Treating Frontotemporal Dementia. Cell chemical biology. 24(7). 892–906.e5. 34 indexed citations
6.
Lalonde, Jasmin, Surya A. Reis, Sudhir Sivakumaran, et al.. (2017). Chemogenomic analysis reveals key role for lysine acetylation in regulating Arc stability. Nature Communications. 8(1). 1659–1659. 16 indexed citations
7.
Reis, Surya A., Balaram Ghosh, J. Adam Hendricks, et al.. (2016). Light-controlled modulation of gene expression by chemical optoepigenetic probes. Nature Chemical Biology. 12(5). 317–323. 74 indexed citations
8.
Ghosh, Balaram, Wen‐Ning Zhao, Surya A. Reis, et al.. (2016). Dissecting structure–activity-relationships of crebinostat: Brain penetrant HDAC inhibitors for neuroepigenetic regulation. Bioorganic & Medicinal Chemistry Letters. 26(4). 1265–1271. 22 indexed citations
9.
Wagner, Florence F., Michel Weïwer, Stefan Steinbacher, et al.. (2016). Kinetic and structural insights into the binding of histone deacetylase 1 and 2 (HDAC1, 2) inhibitors. Bioorganic & Medicinal Chemistry. 24(18). 4008–4015. 63 indexed citations
10.
Schroeder, Frederick A., C. Wang, Genevieve C. Van de Bittner, et al.. (2014). PET Imaging Demonstrates Histone Deacetylase Target Engagement and Clarifies Brain Penetrance of Known and Novel Small Molecule Inhibitors in Rat. ACS Chemical Neuroscience. 5(10). 1055–1062. 29 indexed citations
11.
Santos, Sofia A., Yinghua Guan, J. Adam Hendricks, et al.. (2014). Monoalkoxy BODIPYs—A Fluorophore Class for Bioimaging. Bioconjugate Chemistry. 25(6). 1043–1051. 71 indexed citations
12.
Wang, Changning, Frederick A. Schroeder, Hsiao‐Ying Wey, et al.. (2014). In Vivo Imaging of Histone Deacetylases (HDACs) in the Central Nervous System and Major Peripheral Organs. Journal of Medicinal Chemistry. 57(19). 7999–8009. 75 indexed citations
13.
Schroeder, Frederick A., Michael C. Lewis, Daniel M. Fass, et al.. (2013). A Selective HDAC 1/2 Inhibitor Modulates Chromatin and Gene Expression in Brain and Alters Mouse Behavior in Two Mood-Related Tests. PLoS ONE. 8(8). e71323–e71323. 105 indexed citations
14.
Sheridan, Steven D., Kraig M. Theriault, Surya A. Reis, et al.. (2011). Epigenetic Characterization of the FMR1 Gene and Aberrant Neurodevelopment in Human Induced Pluripotent Stem Cell Models of Fragile X Syndrome. PLoS ONE. 6(10). e26203–e26203. 228 indexed citations
15.
Reis, Surya A., Morgan N. Thompson, Jong‐Min Lee, et al.. (2011). Striatal neurons expressing full-length mutant huntingtin exhibit decreased N-cadherin and altered neuritogenesis. Human Molecular Genetics. 20(12). 2344–2355. 30 indexed citations
16.
Fass, Daniel M., Balaram Ghosh, Krista M. Hennig, et al.. (2010). Short-Chain HDAC Inhibitors Differentially Affect Vertebrate Development and Neuronal Chromatin. ACS Medicinal Chemistry Letters. 2(1). 39–42. 74 indexed citations
17.
Reis, Surya A., Ben A. Oostra, & Rob Willemsen. (2006). Isolation of mouse neuritic mRNAs. Journal of Molecular Histology. 37(1-2). 79–86. 2 indexed citations
18.
Reis, Surya A., Rob Willemsen, Leontine van Unen, A. T. Hoogeveen, & Ben A. Oostra. (2004). Prospects of TAT-Mediated Protein Therapy for Fragile X Syndrome. Journal of Molecular Histology. 35(4). 389–395. 8 indexed citations
19.
Schrier, Mariëtte, et al.. (2004). Transport kinetics of FMRP containing the I304N mutation of severe fragile X syndrome in neurites of living rat PC12 cells. Experimental Neurology. 189(2). 343–353. 25 indexed citations
20.
Zalfa, Francesca, et al.. (2003). The Fragile X Syndrome Protein FMRP Associates with BC1 RNA and Regulates the Translation of Specific mRNAs at Synapses. Cell. 112(3). 317–327. 550 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026